Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$9.49 USD
-0.22 (-2.27%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $9.50 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: AMC |
6/2024 | $-0.48 | 0.00% |
Earnings Summary
For their last quarter, Arcutis Biotherapeutics (ARQT) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.60 per share. This reflects a positive earnings surprise of 46.67%. Look out for ARQT's next earnings release on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.48 per share, reflecting a year-over-year increase of 58.62%.
Earnings History
Price & Consensus
Zacks News for ARQT
Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know
ARQT: What are Zacks experts saying now?
Zacks Private Portfolio Services